首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12篇
  免费   0篇
教育   2篇
科学研究   10篇
  2022年   1篇
  2020年   1篇
  2019年   1篇
  2017年   1篇
  2015年   1篇
  2014年   3篇
  2011年   2篇
  2006年   1篇
  1997年   1篇
排序方式: 共有12条查询结果,搜索用时 0 毫秒
11.
The goal of this paper is to propose an optimal fault tolerant control (FTC) approach for multi-agent systems (MASs). It is assumed that the agents have identical affine dynamics. The underlying communication topology is assumed to be a directed graph. The concepts of both inverse optimality and partial stability are further employed for designing the control law fully developed in the paper. Firstly, the optimal FTC problem for linear MASs is formulated and then it is extended to MASs with affine nonlinear dynamics. To solve the Hamilton-Jacobi-Bellman (HJB) equation, an Off-policy Reinforcement Learning is used to learn the optimal control law for each agent. Finally, a couple of numerical examples are provided to demonstrate the effectiveness of the proposed scheme.  相似文献   
12.
Carboplatin is a chemotherapeutic agent used against various malignancies such as ovarian carcinoma. The aim of this study is to improve the therapeutic efficacy of carboplatin using pegylated liposomal nanocarriers. Nanoparticles were synthesized using thin film hydration technique and characterized for shape morphology, particle size, zeta potential and drug-release properties. In the next step, A2780S and A2780CP ovarian cancer cell lines were used to determine the efficacy of nanodrug by MTT assay. The particle size and zeta potential of nanodrug were measured 244.3 ± 19.6 nm and ?22.9 ± 1.7 mV, respectively. High encapsulation capacity (78.6 ± 3.7 %) confirmed the efficiency of technique. The cytotoxicity results also showed that nanodrug compared to free drug improve the efficacy of carboplatin against both A2780S (P < 0.01) and A2780CP (P < 0.05) cell lines. In conclusion, the findings of our study suggested pegylated liposomal nanocarriers are proper for carboplatin delivery to ovarian cancer cell lines A2780S and A2780CP.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号